83 related articles for article (PubMed ID: 9362160)
1. Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group.
J Natl Cancer Inst; 1997 Nov; 89(21):1616-20. PubMed ID: 9362160
[TBL] [Abstract][Full Text] [Related]
2. Overcoming the Straw Man Effect in Oncology: Visualization and Ranking of Chemotherapy Regimens Using an Information Theoretic Approach.
Warner JL; Yang PC; Alterovitz G
JCO Clin Cancer Inform; 2017 Nov; 1():1-9. PubMed ID: 30657401
[TBL] [Abstract][Full Text] [Related]
3. A good outcome.
Wildes TM; Fabbiano K
J Geriatr Oncol; 2024 May; ():101794. PubMed ID: 38755039
[No Abstract] [Full Text] [Related]
4. Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia.
Sweet KL; Cortes JE; Apperley JF; Mann M; Mauro MJ; Oehler VG; Ruiz C; Schiffer CA; Ehrlich LA; Pamuk GE; Wynne J; Mehta GU; de Claro RA; Theoret MR; Smith BD; Norsworthy KJ
Clin Cancer Res; 2023 Jun; 29(12):2179-2183. PubMed ID: 36547666
[TBL] [Abstract][Full Text] [Related]
5. Management of Chronic Myeloid Leukemia and Pregnancy: A Bibliometric Analysis (2000-2020).
Wang Y; Jiang L; Li B; Zhao Y
Front Oncol; 2022; 12():826703. PubMed ID: 35321439
[TBL] [Abstract][Full Text] [Related]
6. Impact of metformin on tyrosine kinase inhibitor response in chronic myeloid leukemia.
Pokorny R; Stenehjem DD; Gilreath JA
J Oncol Pharm Pract; 2022 Jun; 28(4):916-923. PubMed ID: 35132891
[TBL] [Abstract][Full Text] [Related]
7. A Double-Edged Sword Role of Cytokines in Prostate Cancer Immunotherapy.
Mao C; Ding Y; Xu N
Front Oncol; 2021; 11():688489. PubMed ID: 34868907
[TBL] [Abstract][Full Text] [Related]
8. The effects of oral anticancer parity laws on out-of-pocket spending and adherence among commercially insured patients with chronic myeloid leukemia.
Spargo A; Yost C; Squires P; Raju A; Schroader B; Brown JD
J Manag Care Spec Pharm; 2021 May; 27(5):554-564. PubMed ID: 33908275
[No Abstract] [Full Text] [Related]
9. Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.
Yung Y; Lee E; Chu HT; Yip PK; Gill H
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33440869
[TBL] [Abstract][Full Text] [Related]
10. Validation of the EUTOS Long-Term Survival Score in Chinese Chronic Myeloid Leukemia Patients Treated with Imatinib: A Multicenter Real-World Study.
Yang X; Bai Y; Shi M; Zhang W; Niu J; Wu C; Zhang L; Xu Z; Liu X; Chen Y; Sun K
Cancer Manag Res; 2020; 12():1293-1301. PubMed ID: 32110103
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase inhibitors and interferon-α increase tunneling nanotube (TNT) formation and cell adhesion in chronic myeloid leukemia (CML) cell lines.
Omsland M; Andresen V; Gullaksen SE; Ayuda-Durán P; Popa M; Hovland R; Brendehaug A; Enserink J; McCormack E; Gjertsen BT
FASEB J; 2020 Mar; 34(3):3773-3791. PubMed ID: 31945226
[TBL] [Abstract][Full Text] [Related]
12. Cytokines in Cancer Immunotherapy.
Waldmann TA
Cold Spring Harb Perspect Biol; 2018 Dec; 10(12):. PubMed ID: 29101107
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients.
Hjorth-Hansen H; Stentoft J; Richter J; Koskenvesa P; Höglund M; Dreimane A; Porkka K; Gedde-Dahl T; Gjertsen BT; Gruber FX; Stenke L; Eriksson KM; Markevärn B; Lübking A; Vestergaard H; Udby L; Bjerrum OW; Persson I; Mustjoki S; Olsson-Strömberg U
Leukemia; 2016 Sep; 30(9):1853-60. PubMed ID: 27133821
[TBL] [Abstract][Full Text] [Related]
14. The Role of New Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia.
Pophali PA; Patnaik MM
Cancer J; 2016; 22(1):40-50. PubMed ID: 26841016
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances the clinical responses to interferon-α (IFN) in newly diagnosed chronic myeloid leukemia (CML).
Zeidner JF; Gladstone DE; Zahurak M; Matsui WH; Gocke C; Jones RJ; Smith BD
Leuk Res; 2014 Aug; 38(8):886-90. PubMed ID: 25012565
[TBL] [Abstract][Full Text] [Related]
16. Interferon alfa versus interferon alfa plus cytarabine combination therapy for chronic myeloid leukemia: a meta-analysis of randomized controlled trials.
Chen R; Ma B; Yang K; Tian J; Liu Y; Zhao L
Curr Ther Res Clin Exp; 2011 Aug; 72(4):150-63. PubMed ID: 24648585
[TBL] [Abstract][Full Text] [Related]
17. European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients.
Yamamoto E; Fujisawa S; Hagihara M; Tanaka M; Fujimaki K; Kishimoto K; Hashimoto C; Itabashi M; Ishibashi D; Nakajima Y; Tachibana T; Kawasaki R; Kuwabara H; Koharazawa H; Yamazaki E; Tomita N; Sakai R; Fujita H; Kanamori H; Ishigatsubo Y
Cancer Sci; 2014 Jan; 105(1):105-9. PubMed ID: 24450386
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Treatment Response in CML in View of Current Recommendations for Treatment and Monitoring.
von Bubnoff N
Ther Adv Hematol; 2011 Apr; 2(2):95-110. PubMed ID: 23556080
[TBL] [Abstract][Full Text] [Related]
19. The patient journey in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapies: qualitative insights using a global ethnographic approach.
Guilhot F; Coombs J; Szczudlo T; Zernovak O; Paolantonio M; Bender C; Macdonald NJ; Shapiro A
Patient; 2013; 6(2):81-92. PubMed ID: 23529848
[TBL] [Abstract][Full Text] [Related]
20. Re-emergence of interferon-α in the treatment of chronic myeloid leukemia.
Talpaz M; Hehlmann R; Quintás-Cardama A; Mercer J; Cortes J
Leukemia; 2013 Apr; 27(4):803-12. PubMed ID: 23238589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
